OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Altomare on Treatment Options in ITP

April 1st 2020

Ivy P. Altomare, MD, discusses treatment options for patients with immune thrombocytopenia purpura.

Dr. Boorjian on Research With Nadofaragene Firadenovec in Nonmuscle Invasive Bladder Cancer

April 1st 2020

Stephen A. Boorjian, MD, professor of urology, Mayo Clinic, discusses research with intravesical nadofaragene firadenovec in patients with nonmuscle invasive bladder cancer (NMIBC).

Dr. Rosenberg on Enfortumab Vedotin/Pembrolizumab in Urothelial Carcinoma

April 1st 2020

Jonathan E. Rosenberg, MD, medical oncologist, chief, Genitourinary Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses the updated results of the phase Ib/II EV-103 trial (NCT03288545) with enfortumab vedotin-ejfv (Padcev) and pembrolizumab (Keytruda) in patients with locally advanced or metastatic urothelial carcinoma.

Dr. Carbone Provides Perspective on COVID-19

April 1st 2020

David P. Carbone, MD, PhD, director of the Thoracic Oncology Center at The Ohio State University Comprehensive Cancer Center–James, provides perspective on the novel coronavirus 2019 (COVID-19).

Dr. Dawar on Challenges With Neratinib in Metastatic HER2+ Breast Cancer

April 1st 2020

Richa Dawar, MD, discusses challenges with the use of neratinib in patients with metastatic HER2-positive breast cancer.

Dr. Singal on Systemic Therapies in HCC

April 1st 2020

Amit G. Singal, MD, discusses systemic therapies in hepatocellular carcinoma.

Dr. Jochelson on the Limitations of Mammography and Ultrasound in Screening for Breast Cancer

April 1st 2020

Maxine S. Jochelson, MD, discusses the limitations of mammography and ultrasound in screening patients for breast cancer.

Dr. Socinski on Recommendations for Molecular Testing in Lung Cancer

March 31st 2020

Mark A. Socinski, MD, discusses his recommendations for conducting molecular testing in lung cancer.

Dr. Kelly on Challenges With Starting Immunotherapy in Lung Cancer

March 31st 2020

Karen Kelly, MD, discusses challenges with choosing when to start immunotherapy in patients with lung cancer.

Dr. Foss on the Unmet Need in Cutaneous T-cell Lymphoma

March 31st 2020

Francine Foss, MD, discusses the challenges faced in cutaneous T-cell lymphoma.

Dr. Levine on Programmed Anticancer Immunity With T-cell and NK-cell Therapies

March 31st 2020

Bruce L. Levine, PhD, discusses engineered anticancer immunity with T-cell and natural killer–cell therapies.

Dr. Curran on the Integration of Immunotherapy With Radiation Therapy in Lung Cancer

March 31st 2020

Walter J. Curran, Jr, MD, FACR, FASCO, explains the eligibility criteria for immunotherapy and radiation in patients with lung cancer.

Dr. Donington on Neoadjuvant Immunotherapy in Lung Cancer

March 31st 2020

Jessica Donington, MD, MSCR, discusses the effectiveness of neoadjuvant immunotherapy and how it compares with neoadjuvant chemotherapy in patients with lung cancer.

Dr. Burtness on the Effectiveness of Immunotherapy in Head and Neck Cancers

March 31st 2020

Barbara Burtness, MD, discusses the effectiveness of immunotherapy in patients with platinum-refractory head and neck cancers.

Dr. Pavlick on Sequencing Challenges in BRAF-Mutant Melanoma Treatment

March 31st 2020

Anna C. Pavlick, DO, discusses sequencing challenges faced in the treatment of patients with BRAF-mutant melanoma.

Dr. Berdeja on Updated Data With bb21217 in Multiple Myeloma

March 31st 2020

Jesus Berdeja, MD, the director of Multiple Myeloma Research at Sarah Cannon Research Institute, discusses updated data with bb21217 in multiple myeloma.

Dr. Soto Perez de Celis on COVID-19 Risk Reduction

March 31st 2020

Enrique Soto Pérez de Celis, MD, MSc, a geriatric oncologist and researcher in the Department of Geriatrics at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City, Mexico, discusses ways to reduce the risk of contracting the novel coronavirus 2019 (COVID-19).

Dr. Vargas on the Utility of Sentinel Node Biopsy in Breast Cancer

March 31st 2020

Hernan Vargas, MD, FACS, a breast surgeon at Virginia Cancer Specialists, discusses the utility of sentinel lymph node biopsy in breast cancer.

Dr. Oh on Results From the PRINT Trial in mCRPC

March 31st 2020

William K. Oh, MD, sheds light on the results of the phase II PRINT trial in metastatic castration-resistant prostate cancer.

Dr. Sartor on Implications of PSMA-PET Positivity in Prostate Cancer

March 31st 2020

A. Oliver Sartor, MD, discusses the implications of prostate-specific membrane antigen-PET positivity in prostate cancer.